Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dulaglutide
dulaglutide
FDA Approves Lilly's Once-Weekly Shot For Diabetes
Forbes
Thu, 09/18/14 - 07:28 pm
FDA
Eli Lilly
diabetes
Trulicity
dulaglutide
Novo chief Sorensen preps for showdown as Lilly's dulaglutide nears diabetes market
Fierce Biotech
Tue, 08/19/14 - 08:21 am
dulaglutide
Novo Nordisk
Eli Lilly
Lars Sorenson
diabetes
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Fierce Biotech
Mon, 06/9/14 - 01:21 pm
Victoza
Eli Lilly
diabetes
dulaglutide
Will Cymbalta Break Eli Lilly?
Seeking Alpha
Tue, 04/15/14 - 10:11 am
Eli Lilly
Cymbalta
dulaglutide
patents
Evista
China
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Eli Lilly
diabetes
patents
dulaglutide
GLP-1 agonist
Novo Nordisk
AstraZeneca
GSK
JNJ
Eli Lilly Gains Slightly on Dulaglutide Data
Yahoo/Zacks.com
Thu, 02/27/14 - 04:56 pm
Eli Lilly
dulaglutide
diabetes
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:03 pm
Victoza
Novo Nordisk
Eli Lilly
dulaglutide
diabetes
Bydureon
AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
AstraZeneca
dulaglutide
GSK
Eli Lilly
Bydureon
diabetes
Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tue, 02/25/14 - 08:15 am
Eli Lilly
diabetes
Victoza
Novo Nordisk
dulaglutide
Could These Potential Catalysts Drive Lilly Higher?
Motley Fool
Tue, 02/4/14 - 06:58 pm
Eli Lilly
Evista
Zyprexa
Cymbalta
generics
solanezumab
Alzheimer's disease
LY2963016
diabetes
empagliflozin
dulaglutide
Eli Lilly: 2014 Predictions
Seeking Alpha
Tue, 01/21/14 - 09:42 am
Eli Lilly
dulaglutide
empagliflozin
solanzemab
ramucirumab
Evista
Gemzar
3 New Diabetes Drugs Possibly on the Way Soon
Motley Fool
Wed, 08/21/13 - 09:03 am
diabetes
Forixga
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Eli Lilly
Afrezza
MannKind
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Eli Lilly
diabetes
dulaglutide
JNJ
Merck
Novo Nordisk
Bristol-Myers Squibb
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Seeking Alpha
Thu, 06/20/13 - 11:00 am
Eli Lilly
patents
empagliflozin
dulaglutide
ixekizumab
ramucirumab
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Mon, 06/17/13 - 09:17 am
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
Tue, 04/23/13 - 07:54 am
Eli Lily
diabetes
insulin
LY2605541
dulaglutide
LY2963016
empagliflozin
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
Wed, 04/17/13 - 04:40 pm
diabetes
Eli Lilly
dulaglutide
Novo Nordisk
Sanofi
Lilly diabetes drug as good as insulin in study
Reuters
Tue, 04/16/13 - 10:15 am
Eli Lilly
insulin
diabetes
dulaglutide
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Merck
Sanofi
Eli Lilly
diabetes
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Amylin
Pages
1
2
next ›
last »